Status:
RECRUITING
Telemonitoring Platform "CUREETY TECHCARE" vs Standard of Care for mTBNC Patients Initiating a First-line Treatment
Lead Sponsor:
UNICANCER
Collaborating Sponsors:
Cureety
Conditions:
Metastatic Triple-Negative Breast Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to assess whether adding telemonitoring (the digital telemonitoring platform "CUREETY TECHCARE"), to standard care, will benefit patients with previously untreated m...
Eligibility Criteria
No eligibility criteria provided.
Key Trial Info
Start Date :
July 25 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 2 2028
Estimated Enrollment :
472 Patients enrolled
Trial Details
Trial ID
NCT06505018
Start Date
July 25 2024
End Date
September 2 2028
Last Update
September 2 2025
Active Locations (51)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de Cancérologie des Hauts-de-France (ICHF)
Arras, France
2
Centre Hospitalier d'Auxerre
Auxerre, France
3
Sainte Catherine - Institut du Cancer Avignon Provence
Avignon, France
4
CH Aunay-Bayeux
Bayeux, France